Arylacetamide deacetylase (AADAC)
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.
This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Small volumes of AADAC recombinant protein may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice.
Store at -20 degree C. For extended storage, store at -20 or -80 degree C.
PBS pH 7.4, 50% glycerol
This product is for research use only. Not for use in diagnostic or therapeutic procedures.